Revolutionizing Skincare: Lira Clinical’s REGEN Line Harnesses the Power of Wild Salmon Stem Cells
California-based skincare pioneer, Lira Clinical, has launched its most groundbreaking product line to date: the REGEN line. This is the first-ever clinical skincare range to incorporate Wild Salmon Stem Cell–Conditioned Media, a cutting-edge biotechnology ingredient that reportedly delivers four times the regenerative power of PDRN alone.
Unveiled in mid-July 2026, the REGEN collection is a collaborative effort with Wildtype. It signifies a significant advancement in what Lira Clinical refers to as “PROAging” skincare. This approach emphasizes cellular health and long-term skin renewal, moving beyond mere surface correction.
The exclusive formula of the REGEN line blends Wild Salmon Stem Cell Conditioned Media (also known as Marine Cellular Complex), PDRN, and Copper Tripeptide-1. These ingredients work synergistically to bolster the three fundamental pillars of skin health: hydration, circulation, and firmness. The active ingredients are transported deep into the skin using Lira Clinical’s proprietary EXO-tech™ encapsulation technology, which bypasses the acid mantle for optimal bioavailability.
Unlike conventional brightening products that only work on the skin’s surface, REGEN’s “Clinical Brightening” strategy targets the root causes of dullness and uneven tone. This supports the skin’s natural renewal processes, resulting in a complexion that appears genuinely healthier and more vibrant.
Founded by four esteemed skincare professionals, Lira Clinical’s guiding principle is “Science Discovering Nature’s Secrets.” The brand operates on a global scale from its headquarters in Livermore, California.
Source: GlobeNewswire – Lira Clinical Announces New REGEN Line